CDC encourages additional COVID-19 vaccine dose for patients 65 and older

CDC changes community COVID-19 isolation guidance; does not change guidance for Vanderbilt Health employees, patients or facilities

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

Team uses COVID-19 to test automated acute disease profiling

An automated solution for creating phenotyping algorithms, PheNorm, worked well to identify symptomatic COVID-19 cases in electronic health records, suggesting that automation could speed high-throughput phenotyping of acute disease.

Children’s antibodies highly potent against COVID-19: study

Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants.

Updated COVID-19 vaccine available for VUMC employees and patients

The Food and Drug Administration (FDA) recently approved an updated mRNA COVID-19 vaccine. The vaccine provides better protection against current strains of COVID-19 that are circulating as we transition into the fall/winter virus season.